These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2962987)

  • 1. Adenocarcinoma of the prostate.
    Finan B; Atkinson WE; Cockrill HH; Landgren RC; Ross SW
    J Ark Med Soc; 1987 Dec; 84(7):283-4. PubMed ID: 2962987
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radiotherapy of prostate cancer].
    Kellokumpu-Lehtinen P; Huovinen R
    Duodecim; 1989; 105(19):1590-5. PubMed ID: 2680450
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal management of prostatic cancer.
    Albertsen P; Marshall F
    Geriatrics; 1982 Dec; 37(12):69-72, 77-9. PubMed ID: 7141229
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of prostatic carcinoma from the urological viewpoint].
    Burchardt P
    Rontgenblatter; 1973 Oct; 26(10):432-4. PubMed ID: 4752187
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
    Berenguer Sánchez A
    Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prostatic adenocarcinoma. III. Results of radical treatment. Review of the literature].
    Valls Fontanals A; Panadés Nigorra G; Ballester Moll T
    Actas Urol Esp; 1985; 9(2):121-6. PubMed ID: 3893054
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
    Rapkiewicz A; Gorokhovsky R; Farcon E; Das K
    Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsurgical management of patients with stage D1 adenocarcinoma of prostate: risks vs benefits.
    deVere White R
    Urology; 1984 Nov; 24(5 Suppl):12-5. PubMed ID: 6541825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone.
    Granfors T; Modig H; Damber JE; Tomic R
    J Urol; 2006 Aug; 176(2):544-7. PubMed ID: 16813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of prostatic cancer].
    J Urol (Paris); 1984; 90(10):619-48. PubMed ID: 6242517
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of advanced prostatic cancer].
    Hedlund PO
    Lakartidningen; 2000 Aug; 97(32-33):3466-9. PubMed ID: 11037588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure.
    Utz DC
    Urology; 1984 Nov; 24(5 Suppl):4-11. PubMed ID: 6495469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inferior vena cava obstruction secondary to adenocarcinoma of the prostate. Role of orchiectomy in treatment.
    Benderev TV; Grayhack JT; Bockrath JM; Uke ET
    Arch Intern Med; 1986 Mar; 146(3):598-9. PubMed ID: 3954533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goserelin (Zoladex) or orchiectomy in metastatic prostate cancer? A quality of life and cost-effectiveness analysis.
    Nygård R; Norum J; Due J
    Anticancer Res; 2001; 21(1B):781-8. PubMed ID: 11299844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials referral resource. Prostate cancer.
    Cheson BD; Kaplan RS; Phillips PH
    Oncology (Williston Park); 1994 Dec; 8(12):35-6. PubMed ID: 7534101
    [No Abstract]   [Full Text] [Related]  

  • 16. Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.
    Foote JE; Crawford ED
    Semin Urol; 1988 Nov; 6(4):291-302. PubMed ID: 3068767
    [No Abstract]   [Full Text] [Related]  

  • 17. More on the Uro-Oncology Research Group report of radical surgery vs. radiotherapy for adenocarcinoma of the prostate.
    Hanks GE
    Int J Radiat Oncol Biol Phys; 1988 May; 14(5):1053-4. PubMed ID: 3360648
    [No Abstract]   [Full Text] [Related]  

  • 18. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for stage C or D1 adenocarcinoma of the prostate: possible beneficial effect of adjuvant treatment.
    Zincke H
    NCI Monogr; 1988; (7):109-15. PubMed ID: 3173496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Curative treatment of prostatic cancer in Norway in 1998 and 2001].
    Kvåle R; Skarre E; Tønne A; Kyrdalen AE; Norstein J; Angelsen A; Wahlqvist R; Fosså SD
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):912-6. PubMed ID: 16554883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of treatment on the local lesion of carcinoma of the prostate.
    Cosgrove MD; George FW; Terry R
    J Urol; 1973 May; 109(5):861-5. PubMed ID: 4633542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.